Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malignant Lymphoma

  Free Subscription


14.06.2021

1 Am J Clin Pathol
2 Am J Hematol
1 Am J Surg Pathol
3 Blood
3 Br J Dermatol
3 Br J Haematol
2 Curr Treat Options Oncol
1 Dtsch Med Wochenschr
1 Haematologica
1 Hum Pathol
2 Lancet Oncol
10 Leuk Lymphoma
2 Leukemia
2 N Engl J Med
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Pathol

  1. DIAZ-PEREZ JA, Poveda JC, Chapman JR, Velez-Torres JM, et al
    Unexpected Primary Extranodal Marginal Zone Lymphoma of Bone in Amputation and Arthroplasty Specimens.
    Am J Clin Pathol. 2021 Jun 2. pii: 6291038. doi: 10.1093.
    PubMed         Abstract available


    Am J Hematol

  2. MARTINEZ-CALLE N, Wilson MR, Eyre TA, Cwynarski K, et al
    Interpretation of retrospective data evaluating high-dose methotrexate as central nervous system prophylaxis in Diffuse Large B-cell Lymphoma; caution required.
    Am J Hematol. 2021 May 29. doi: 10.1002/ajh.26257.
    PubMed        

  3. PUCKRIN R, Stewart DA
    Prophylactic high-dose methotrexate in diffuse large B cell lymphoma, authors' response.
    Am J Hematol. 2021 May 29. doi: 10.1002/ajh.26256.
    PubMed        


    Am J Surg Pathol

  4. VOLARIC AK, Gru AA
    PD-1 and PD-L1 Immunohistochemistry as a Diagnostic Tool for Classic Hodgkin Lymphoma in Small-volume Biopsies.
    Am J Surg Pathol. 2021 Jun 3. pii: 00000478-900000000-97192.
    PubMed        


    Blood

  5. KORONA B, Korona D, Zhao W, Wotherspoon A, et al
    GPR34 activation potentially bridges lymphoepithelial lesion to genesis of salivary gland MALT lymphoma.
    Blood. 2021 Jun 4. pii: 476070. doi: 10.1182/blood.2020010495.
    PubMed         Abstract available

  6. WILLIAMS ME
    Mantle cell lymphoma continues to surprise, and inform!
    Blood. 2021;137:3158-3160.
    PubMed        

  7. CAI J, Qing X
    Splenic marginal zone lymphoma with increased prolymphocytes.
    Blood. 2021;137:3150.
    PubMed        


    Br J Dermatol

  8. MOLLOY K, Vico C, Ortiz-Romero PL, Scarisbrick JJ, et al
    Real-world experience of using mogamulizumab in relapsed/refractory mycosis fungoides/Sezary syndrome.
    Br J Dermatol. 2021;184:978-981.
    PubMed        

  9. HODAK E, Sherman S, Papadavid E, Bagot M, et al
    Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.
    Br J Dermatol. 2021;184:524-531.
    PubMed         Abstract available

  10. PORCU P, Nikbakht N
    New insights on treatment utilization and outcomes in early-stage mycosis fungoides.
    Br J Dermatol. 2021;184:594-595.
    PubMed        


    Br J Haematol

  11. SIMA A, Hollander P, Baecklund E, Smedby KE, et al
    Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden.
    Br J Haematol. 2021 Jun 9. doi: 10.1111/bjh.17577.
    PubMed         Abstract available

  12. KOWA JY, Millard T, Goldman A, Sharma RK, et al
    Are treatment response assessment maps (TRAMs) and (18) F-choline positron emission tomography the future of central nervous system lymphoma imaging?
    Br J Haematol. 2021 Jun 9. doi: 10.1111/bjh.17632.
    PubMed        

  13. SABATINI PJB, Tremblay-LeMay RMA, Ahmadi Moghaddam P, Delabie JMA, et al
    Marginal zone lymphoma transdifferentiated to histiocytic sarcoma.
    Br J Haematol. 2021 Jun 7. doi: 10.1111/bjh.17582.
    PubMed        


    Curr Treat Options Oncol

  14. GALLOWAY E, Griffith M, Rosenthal A
    Multidisciplinary Management of Adolescent and Young Adult Patients with Hodgkin Lymphoma.
    Curr Treat Options Oncol. 2021;22:64.
    PubMed         Abstract available

  15. LAP CJ, Nassereddine S, Dunleavy K
    Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma.
    Curr Treat Options Oncol. 2021;22:60.
    PubMed         Abstract available


    Dtsch Med Wochenschr

  16. HENTRICH M
    [Diagnosis and treatment of HIV-associated lymphoma: Update 202].
    Dtsch Med Wochenschr. 2021;146:724-727.
    PubMed         Abstract available


    Haematologica

  17. PECE R, Tavella S, Costa D, Varesano S, et al
    Inhibitors of A Disintegrin And Metalloproteinases-10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect.
    Haematologica. 2021 Jun 10. doi: 10.3324/haematol.2021.278469.
    PubMed         Abstract available


    Hum Pathol

  18. WANG W, Zhang Q, Medeiros LJ
    Syncytial Variant of Nodular Sclerosis Hodgkin Lymphoma: An Under-emphasized Variant.
    Hum Pathol. 2021 May 28. pii: S0046-8177(21)00093.
    PubMed         Abstract available


    Lancet Oncol

  19. PULSONI A
    Pembrolizumab for relapsed or refractory Hodgkin lymphoma.
    Lancet Oncol. 2021;22:e234.
    PubMed        

  20. KURUVILLA J
    Pembrolizumab for relapsed or refractory Hodgkin lymphoma - Author's reply.
    Lancet Oncol. 2021;22:e235.
    PubMed        


    Leuk Lymphoma

  21. ALVAREZ E, Le T, Kahn J, Winestone L, et al
    Comorbidities and socioeconomic status are predictors of survival in children and young adults with Burkitt lymphoma.
    Leuk Lymphoma. 2021 Jun 1:1-7. doi: 10.1080/10428194.2021.1932873.
    PubMed        

  22. MOZAS P, Lopez-Guillermo A
    Response to: The lymphocyte-to-monocyte ratio in follicular lymphoma.
    Leuk Lymphoma. 2021 Jun 1:1-2. doi: 10.1080/10428194.2021.1933482.
    PubMed        

  23. RODRIGUES JM, Porwit A, Hassan M, Ek S, et al
    Targeted genomic investigations in a population-based cohort of mantle cell lymphoma reveal novel clinically relevant targets.
    Leuk Lymphoma. 2021 Jun 3:1-11. doi: 10.1080/10428194.2021.1933480.
    PubMed         Abstract available

  24. CHEN Q, Liu S, Zhang K, Yu B, et al
    Hsa-miR-372-5p regulates the NIMA related kinase 7 and IL-1beta release in NK/T-cell lymphoma.
    Leuk Lymphoma. 2021 Jun 3:1-9. doi: 10.1080/10428194.2021.1933472.
    PubMed         Abstract available

  25. TREVINO KM, Martin P, Saracino R, Leonard JP, et al
    Unmet need for mental health services in indolent lymphoma: age differences over one-year post-diagnosis.
    Leuk Lymphoma. 2021;62:1370-1378.
    PubMed         Abstract available

  26. SORIGUE M, Sancho JM
    The lymphocyte-to-monocyte ratio in follicular lymphoma.
    Leuk Lymphoma. 2021 Jun 8:1-4. doi: 10.1080/10428194.2021.1929965.
    PubMed        

  27. MINSON A, Dickinson M
    Too much, or not enough? The enduring uncertainty of maintenance rituximab for transformed follicular lymphoma.
    Leuk Lymphoma. 2021 Jun 9:1-3. doi: 10.1080/10428194.2021.1938033.
    PubMed        

  28. BRAM EDNERSSON S, Stern M, Fagman H, Nilsson-Ehle H, et al
    Proteomic analysis in diffuse large B-cell lymphoma identifies dysregulated tumor microenvironment proteins in non-GCB/ABC subtype patients.
    Leuk Lymphoma. 2021 Jun 11:1-14. doi: 10.1080/10428194.2021.1913147.
    PubMed         Abstract available

  29. MOZESSOHN L, Zhang L, Odejide OO, Chen R, et al
    Prognostic value of disease risk score versus gait speed in older adults with lymphoma.
    Leuk Lymphoma. 2021 Jun 11:1-8. doi: 10.1080/10428194.2021.1938029.
    PubMed         Abstract available

  30. KARALEXI MA, Pourtsidis A, Panagopoulou P, Moschovi M, et al
    Overall and event-free survival of childhood lymphoma in Greece: analysis of harmonized clinical data over a 24-year active registration period.
    Leuk Lymphoma. 2021 Jun 11:1-13. doi: 10.1080/10428194.2021.1907376.
    PubMed         Abstract available


    Leukemia

  31. LITTLE MP, Wakeford R, Zablotska LB, Borrego D, et al
    Lymphoma and multiple myeloma in cohorts of persons exposed to ionising radiation at a young age.
    Leukemia. 2021 May 28. pii: 10.1038/s41375-021-01284.
    PubMed         Abstract available

  32. JACHIMOWICZ RD, Klapper W, Glehr G, Muller H, et al
    Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP.
    Leukemia. 2021 Jun 10. pii: 10.1038/s41375-021-01314.
    PubMed        


    N Engl J Med

  33. SEHN LH, Salles G
    Diffuse Large B-Cell Lymphoma. Reply.
    N Engl J Med. 2021;384:2262.
    PubMed        

  34. LANG R, Gill MJ
    Diffuse Large B-Cell Lymphoma.
    N Engl J Med. 2021;384:2261-2262.
    PubMed        


    Proc Natl Acad Sci U S A

  35. FANGAZIO M, Ladewig E, Gomez K, Garcia-Ibanez L, et al
    Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: